Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on... see more

CSE:QNTM - Post Discussion

Quantum BioPharma Ltd > Million Dollar meeting
View:
Post by GrahamB on Jan 02, 2022 8:46pm

Million Dollar meeting

Interesting snippets from the last financials:

“The Company reimbursed certain directors C$1,334,158 for expenses incurred in relation to requisitioning, calling and holding the shareholders' meeting.”

 

PAGE 27 www.sedar.com

Those directors are so selfless, and shareholder friendly!

Comment by JAKPUG4LIFE on Jan 02, 2022 8:55pm
Ouch....what expenses? You have to wonder about this share buyback as well. Funny how they bought shares as the news came out and not even close to the lucid deal...... "in order to allow the company to use its excess cash reserves to strategically return value to shareholders." Shareholders will never see their money back so strategically I think we know who it will benefit " ...more  
Comment by pedro7 on Jan 02, 2022 9:42pm
Wonder how much Rosey was paid. Oh sorry likely paid directly from AD.
Comment by gossamer4 on Jan 03, 2022 1:51am
This post has been removed in accordance with Community Policy
Comment by GrahamB on Jan 03, 2022 4:40am
Hey JAKP we will see if they purchase many shares, or whether this was just a PR move to show support for the stock. Almost everyone could care less about aFSD Then again, if it taNKS below a dollar, it could be strategic just to keep some volume in the stock to avoid it falling lower-so they dont get boooted of NASDAQ- -Dont want to throw away that video of them ringing the bell] This is not ...more  
Comment by rad10 on Jan 03, 2022 6:38am
They rang the nasdaq opening Bell? Oh my that is one of Marc Cohodes "golden tells" / red flags for a potential short...   he called it with Concordia pharma and several others.
Comment by rad10 on Jan 03, 2022 6:41am
Graham - devil is in the details!  Read the news release.  They are under no obligation to guy back any stock whatsoever.
Comment by GrahamB on Jan 03, 2022 9:07am
Exactly. Announcing Possible share buy backs, and making tiny purchases(Possibly money they have made off the company IMO) is a attempt to send a positive signal to the street-promoted by the board cheerleader. Problem is nobody that has any insight will care-and any newbies can look at the horrific chart, and go elsewhere -all imo
Comment by DavidRosenberg on Jan 03, 2022 9:11am
Share buyback program starts Jan 4th 
Comment by Borat138 on Jan 09, 2022 1:24pm
huge scam stock going down under $1 starts tmrw you clown lol
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities